Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sinovac COVID vaccine CoronaVac shows positive results in early trial

Ruchika Sharma16 Jun 2020 9:00 AM IST

The phase II clinical trial results show that the vaccine induces neutralizing antibodies 14 days after the vaccination with a 0,14 day schedule.

Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days

CDSCO reviewing Cipla, Dr Reddys, others applications for Remdesivir on priority: Health Ministry

Ruchika Sharma15 Jun 2020 4:00 PM IST

The CDSCO is awaiting the data and is providing complete support to these companies. It has already waived off the requirement of local clinical...

Govt shows green flag to HCQ for early COVID cases, remdesivir for moderate stage

Ruchika Sharma15 Jun 2020 3:39 PM IST

Under emergency use authorization, remdesivir may be considered for patients in moderate stage requiring oxygen support.

Lupin to approach USFDA for re-inspection of Goa, Pithampur, US plant

Ruchika Sharma15 Jun 2020 12:12 PM IST

The US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of...

Dr Reddy's, Gilead enter licensing pact for investigational COVID drug Remdesivir

Ruchika Sharma15 Jun 2020 11:35 AM IST

Dr. Reddy’s will receive technology transfer from Gilead for the manufacturing of this drug.

AstraZeneca to supply 400 million doses of COVID-19 Vaccine to Europe

Ruchika Sharma15 Jun 2020 9:45 AM IST

AstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine...

Novo Nordisk Once-weekly Insulin Icodec Shows Comparable Efficacy To Once-daily Insulin Glargine U100 in Phase 2 trial

Ruchika Sharma15 Jun 2020 9:30 AM IST

"Novo Nordisk has been at the forefront of insulin innovation for almost 100 years, and we continuously conduct disruptive research that can lead to...

Omron Healthcare, Lupin join hands to strengthen respiratory disease management facilities

Ruchika Sharma14 Jun 2020 10:00 AM IST

Under the collaboration, the two companies will combine their respective strengths to transform the outcomes of respiratory disease management by...

Pfizer Abrocitinib hits mark in phase 3 of Atopic Dermatitis trial

Ruchika Sharma14 Jun 2020 9:45 AM IST

Abrocitinib received Breakthrough Therapy designation from the FDA for the treatment of patients with moderate to severe AD in February 2018, Pfizer...

Sanofi to present growth opportunities, development strategy for Dupixent in type 2 inflammatory diseases

Ruchika Sharma14 Jun 2020 9:15 AM IST

As announced in December 2019, Sanofi expects to deliver strong growth for Dupixent with the ambition of achieving more than €10 billion in peak sales...

Dr Reddy's Labs launches Colchicine Tablets in US

Ruchika Sharma13 Jun 2020 12:34 PM IST

Dr. Reddy's Colchicine is available in 0.6 mg tablets in bottle count sizes of 30s and 1 00s

Zydus Cadila, Gilead ink licensing agreement to manufacture, market Remdesivir

Ruchika Sharma13 Jun 2020 11:25 AM IST

Under the agreement, the license is royalty-free until another pharmaceutical product or vaccine is approved for the treatment or prevention of COVID...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok